SISTER PAGE:  TO DAVID'S KINGDOM: HARM REDUCTION · HIV · HEP C · FTIR · SYRINGE EXCHANGE ↗  ·  Part of the Musica Universalis public health series.
Health · Mind · Society · Science · 2026

Mental Health:
The Reality Behind the Mind

A deep dive into what is real, what is misunderstood, what the numbers actually say, and what you can do about it today. No jargon. No shame. No oversimplification.

1 in 8 people globally live with a mental disorder
700K+ suicide deaths per year worldwide
$1T annual economic loss from depression and anxiety
75% of cases in low-income countries receive no treatment
Section 01 · The Actual Numbers

What the data actually says

Mental health disorders are the leading cause of disability worldwide, accounting for 1 in 6 years lived with disability globally[1] (WHO, 2022). These are not edge cases. They are the statistical center of human experience.

The numbers below are not about "other people." They are about the people sitting next to you on the bus, your coworker who is always tired, your friend who cancels plans.

280M[1]
Depression
People affected globally. Second leading cause of disability. Suicide risk is 20x higher in untreated major depressive disorder compared to general population.
301M
Anxiety Disorders
Most common mental health condition. Generalized anxiety, panic disorder, social anxiety, phobias. Most respond well to treatment; most never receive it.
24M
Schizophrenia
Affects 0.32% of population. Life expectancy 15-20 years shorter than average; mostly from preventable physical health conditions, not the disorder itself.
40M
Bipolar Disorder
Affects 1-2% globally. Often misdiagnosed for 8-10 years. People with bipolar I have a suicide rate 20-30x higher than the general population.
55M
Dementia
10 million new cases per year. Alzheimer's accounts for 60-70% of cases. Currently irreversible; the most underfunded major disease relative to its burden.
14M
Eating Disorders
Anorexia nervosa has the highest mortality rate of any psychiatric disorder: 5-10% per decade. Often dismissed as "a choice." It is not.
4%
ADHD (adults)
Massively underdiagnosed in women and adults. Not a childhood condition that you "grow out of." Associated with significantly higher rates of unemployment, accidents, and relationship difficulties.
3.9%
PTSD
Lifetime prevalence. Much higher in conflict zones, survivors of assault, healthcare workers. Neurologically observable: measurable changes in amygdala and hippocampus volume.
On Suicide · The Numbers That Matter Most

Globally, one person dies by suicide every 40 seconds. It is the fourth leading cause of death among 15-29 year olds. For every death, there are approximately 20 attempts. Men die by suicide at 3-4x the rate of women; women attempt at higher rates. Low- and middle-income countries account for 77% of global suicide deaths. Access to means, social connection, and economic security are the three most powerful predictors. Most people who attempt suicide and survive do not go on to die by suicide. Crisis is survivable. The data is clear on this.

If you are in crisis right now

International Association for Suicide Prevention: iasp.info/resources/Crisis_Centres: directory of crisis lines worldwide.

Crisis Text Line (US, UK, Canada, Ireland): Text HOME to 741741.

988 Suicide and Crisis Lifeline (US): Call or text 988.

You do not have to be "suicidal enough" to call. If you're struggling, that is enough.

· · · ·
Section 02 · Stigma, Truth, and What Is Actually False

What is real. What is not.

Stigma is not just social awkwardness around a topic. It has measurable clinical consequences: people delay seeking treatment by an average of 11 years partly due to stigma. It affects employment, relationships, legal rights, and housing. It is a public health emergency in itself.

Here is what the evidence says, without softening.

❌ False / Stigma / Harmful
  • "Mental illness is a choice or weakness."
  • "People with schizophrenia are violent."
    (They are far more likely to be victims than perpetrators.)
  • "Depression is just being sad. Try harder."
  • "Medication is a crutch. You should manage it naturally."
  • "Therapy is for people who can't handle life."
  • "Suicide is selfish."
    (It is a symptom of overwhelming pain. Full stop.)
  • "ADHD isn't real; kids are just overmedicated."
  • "Eating disorders are about vanity."
  • "Bipolar people are just moody."
  • "Trauma 'toughens you up' if you push through it."
✓ True / Evidence-Based
  • Mental disorders have observable neurological correlates: brain scans, biomarkers, genetics.
  • Most mental health conditions are as biological as diabetes and as treatable.
  • Medication works. Therapy works. Combination is often most effective.
  • Recovery is real. Most people with depression who receive treatment improve significantly.
  • Mental illness is not a personality. It is a condition that happens to a person.
  • Exercise has clinical antidepressant effects comparable to medication in mild-moderate cases.
  • Social connection is the single strongest predictor of long-term mental health outcomes.
  • Asking someone if they are thinking about suicide does not plant the idea. It opens the door.
  • Early intervention dramatically changes lifelong outcomes. Childhood matters.
  • Sleep deprivation causes mental health symptoms in neurotypical people. Sleep is medicine.
What Stigma Actually Is

Stigma is structural (insurance not covering mental health parity with physical), interpersonal (telling someone to "just think positive"), and internalized (refusing to seek help because "I should be able to handle this"). All three are harmful. All three are changeable. Reducing stigma by 30% through community education programs has been shown to increase treatment-seeking by statistically significant amounts. Language matters: "a person with schizophrenia," not "a schizophrenic." "Died by suicide," not "committed suicide." These are not just semantics; they shift how we think.

· · · ·
Section 03 · The Question Nobody Can Fully Answer

What is "normal," anyway?

"Normal" in mental health is a distribution, not a line. The DSM and ICD diagnostic criteria exist not to label people but to identify when a cluster of symptoms causes significant distress or functional impairment. The question is not whether you feel anxious sometimes (everyone does), but whether anxiety is disproportionate, persistent, and limiting your life.

Normal includes: grief that looks like depression for weeks or months. Anxiety spikes during stress. Periods of low motivation. Difficulty concentrating during major life changes. Emotional dysregulation after sleep deprivation. These are not disorders. They are human responses to difficult circumstances.

Not normal, in the clinical sense: symptoms that persist for weeks with no clear cause, that cannot be managed by ordinary life adjustments, that damage relationships or work function, or that cause serious distress regardless of circumstances. When your own mind is working against you consistently, that is when the clinical framework becomes useful, not as a label but as a map.

The Most Useful Single Question

Not "am I normal?" but: "Is this affecting my ability to live the life I want to live?" If yes, it is worth addressing, whether through professional help, lifestyle change, or both. The threshold for seeking help is not severity. It is impact.

· · · ·
Section 04 · The Daily Work

What you can realistically do. Every day.

The research on mental health self-management converges on one uncomfortable truth: small consistent actions outperform occasional heroic efforts. Ten minutes of the right activity, done daily, produces measurable neurological changes over 8-12 weeks. The brain is plastic. It responds to repetition.

These are not "wellness tips." These are interventions with clinical evidence behind them, adapted to realistic daily constraints.

☀️
5 minutes · Morning
Light Exposure
10-30 minutes of natural light within one hour of waking. Not through a window. Outside, even overcast. This resets your circadian rhythm, suppresses melatonin correctly, and has documented antidepressant effects equivalent to light therapy boxes (10,000 lux)3. The single highest-ROI mental health action most people don't do. Even 5 minutes helps.
🫁
5 minutes · Anytime
Physiological Sigh
Double inhale through the nose (inhale, then a quick second inhale to fully inflate alveoli), then a long, slow exhale through the mouth. Repeat 3-5 times. This is the fastest known method to reduce acute physiological stress. It works via CO₂ regulation and vagal nerve stimulation. Stanford research (Huberman, 2023): 5 minutes daily reduces anxiety measurably over 4 weeks.
🚶
10 minutes · Any time
Walking (Outside)
Not exercise walking. Slow, non-goal-directed walking outside. Panoramic vision (not phone-focused) activates a low-arousal state in the nervous system. The combination of bilateral movement (left-right), natural light, and panoramic gaze has documented anxiolytic effects. This is part of why EMDR therapy (bilateral eye movement) works for trauma.4 A 10-minute walk is a legitimate clinical intervention.
📓
5-10 minutes · Evening
Expressive Writing
James Pennebaker's research (UT Austin, 1980s-present): writing about a difficult experience for 15-20 minutes on 3-4 consecutive days reduces depression[2] symptoms, improves immune function, and decreases rumination. The mechanism is narrative integration: turning fragmented emotional memory into coherent story reduces the amygdala's alarm response. You don't need a therapist to do this. You need a pen and privacy.
🎵
10 minutes · Flexible
Musical Therapy (Active)
Listening passively works, but active engagement works more. Sing. Hum along. Play an instrument, even badly. Drum on a table. Music activates the dopamine system, but active participation additionally engages motor cortex, timing systems, and social circuitry (even when alone). The 10-minute threshold matters: below it, mood effects are transient. Above it, cumulative neurological changes accumulate over weeks.
🎨
10+ minutes · Weekly
Making Something
Drawing, cooking, knitting, gardening, woodworking, writing, building anything. The research on "making" and mental health is consistent: creating objects or processes activates a reward circuit tied to mastery and completion that is distinct from passive pleasure. It produces dopamine via effort, not consumption. The hobbyist is not escaping from life. They are building a neurological counterweight to chronic stress.
💪
20 minutes · 3x/week minimum
Resistance or Aerobic Exercise
The antidepressant effect of exercise is not metaphorical. BDNF (brain-derived neurotrophic factor) increases with exercise[3]; it literally promotes the growth of new neurons in the hippocampus, the region most damaged by chronic stress. A 2023 meta-analysis (N=128,000+) found exercise as effective as antidepressants5 for mild-moderate depression[3]. Threshold: 150 minutes/week moderate intensity. Even 10 minutes reduces acute anxiety. Start there.
😴
Non-negotiable · Every night
Sleep Architecture
7-9 hours is not a recommendation[5]. Sleep deprivation of even 1-2 hours/night produces measurable impairment in emotional regulation, working memory, threat detection, and empathy. Chronic mild sleep deprivation (6 hours/night) causes the same cognitive impairment as 24 hours of no sleep, but feels normal because you adapt. Fix: consistent wake time (not bedtime), no screens for 30 min before sleep, cool room (18-19°C), darkness. In that order of importance.
🥗
Every meal · Cumulative
Diet and the Gut-Brain Axis
90% of serotonin is produced in the gut6[6]. The gut-brain axis is bidirectional and real: gut microbiome composition correlates with depression risk, anxiety, and cognitive function. Practical changes with strongest evidence: increase dietary fiber (30g/day), add fermented foods (yogurt, kimchi, kefir), reduce ultra-processed foods, omega-3s (fatty fish or supplement). Not a cure. A foundation. The Mediterranean diet has the most robust evidence for mental health outcomes.7
What Kind of Therapy?

Not all therapy is the same. Here is what the evidence shows.

Cognitive Behavioral Therapy (CBT)

  • Best evidence for: Depression, anxiety disorders, OCD, eating disorders, PTSD, insomnia (CBT-I is the gold standard for insomnia).
  • What it does: Identifies and restructures thought patterns that maintain symptoms. "Your thoughts are not facts."
  • Duration: Typically 8-20 sessions. Skills-based; you practice between sessions.
  • Access: Many free CBT workbooks online. Apps like Woebot (AI-guided CBT) show modest evidence. Best with a trained therapist.
  • Limitation: Requires active engagement. Does not address trauma as directly as EMDR or trauma-focused approaches.

Dialectical Behavior Therapy (DBT)

  • Best evidence for: Borderline personality disorder, chronic suicidality, emotional dysregulation, eating disorders.
  • What it does: Combines CBT with acceptance-based strategies and mindfulness. Teaches distress tolerance, emotion regulation, interpersonal effectiveness.
  • Duration: Typically 6-12 months. Often includes skills group + individual therapy.
  • Unique feature: Designed explicitly for people who have found other therapies don't work and feel "treatment resistant."
  • TIPP skill (fast relief): Temperature (cold water on face), Intense exercise, Paced breathing, Progressive muscle relaxation. Works within minutes for acute distress.

Eye Movement Desensitization and Reprocessing (EMDR)

  • Best evidence for: PTSD, trauma, phobias. WHO-endorsed for PTSD treatment.
  • What it does: Bilateral stimulation (eye movements, tapping) while recalling traumatic memories allows the brain to reprocess and "file" them differently. Mechanism still debated but outcomes are robust.
  • Duration: Often faster than talk therapy for trauma: 3-12 sessions for single-incident trauma.
  • Why it works (hypothesis): Bilateral movement activates the same neural process as REM sleep, which normally consolidates and emotionally neutralizes memories.
  • Note: Should be done with a trained EMDR therapist. Self-directed versions exist but are not recommended for severe trauma.

Psychedelic-Assisted Therapy

  • Evidence stage: Phase 2/3 trials. Not yet FDA-approved for most conditions as of 2026; MDMA for PTSD approval process ongoing.
  • Strongest evidence: Psilocybin for treatment-resistant depression (Johns Hopkins, Imperial College)8: 2-3 sessions producing antidepressant effects lasting months. MDMA for PTSD: 67% no longer met PTSD criteria9[7] after treatment (vs 32% placebo).
  • How it works: Psychedelics temporarily reduce activity in the default mode network (the "self-narrative" brain), allowing reprocessing of difficult material with reduced defensive response. They also dramatically increase neuroplasticity in a short window.
  • Key distinction: The drug is not the therapy. The guided therapy session before and after (integration) is essential. Without it, outcomes are inconsistent.
  • Access: Legal in some jurisdictions (Oregon, Colorado for psilocybin). Clinical trials recruiting globally.

Music Therapy (Clinical)

  • Distinct from: Listening to music you like. Clinical music therapy involves structured interventions by a credentialed music therapist.
  • Best evidence for: Depression, anxiety, dementia (significant reduction in agitation and improvement in mood), autism, Parkinson's (rhythmic auditory stimulation improves gait), schizophrenia (reduces negative symptoms).
  • Active vs receptive: Active (playing, singing, improvising) produces stronger outcomes than receptive (listening). The act of creating music is the therapeutic mechanism, not just the sound.
  • DIY version: Improvise freely on any instrument for 10 minutes without judgment. The goal is not to play well. The goal is to externalize internal states through sound. This is the mechanism.
  • Rhythm specifically: Rhythmic entrainment (your body synchronizing to external rhythm) reduces cortisol and activates parasympathetic nervous system. Drumming, even on a table, counts.

Art Therapy and Creative Practices

  • Evidence base: Moderate. Strongest for trauma, PTSD, cancer patients, children who cannot verbalize experiences.
  • Why it works: Pre-verbal and non-verbal trauma is stored differently in the brain than verbal memory. Creative expression accesses these stores without requiring language. This is especially important for childhood trauma.
  • What counts: Drawing, painting, sculpture, collage, photography, journaling with images. The medium does not matter. The process of making does.
  • The "flow state" mechanism: Deep engagement in creative activity produces a state of high focus and low self-consciousness. This is neurologically similar to meditation and has the same cortisol-reducing effects.
  • Research note: Adult coloring books have documented anxiety-reducing effects. Not because coloring is profound, but because focused fine motor activity with visual reward engages the parasympathetic system. Mechanism over aesthetics.

Peer Support

  • Evidence: Strong for reducing isolation, improving medication adherence, preventing relapse in schizophrenia and substance use disorders. Growing evidence for depression and anxiety.
  • What it is: Support from people with lived experience of similar conditions. Not therapy, but a complement to it.
  • Why it works: Reduces shame through normalization. Provides practical coping strategies from people who have actually used them. Creates social connection, which is the single strongest protective factor against mental health deterioration.
  • Access: NAMI (US), Rethink Mental Illness (UK), SANE Australia peer support lines. Online communities (with curation) on Reddit (r/mentalhealth), Discord servers for specific conditions.
  • Caution: Unmoderated online communities can reinforce symptoms. Choose communities with active moderation and recovery-oriented norms.
· · · ·
Medicine Break · Frontier Research · 2024-2026

What is coming. What is missing. What you can do.

Mental health research is at an inflection point. After decades of incremental progress, several fields are producing results that are genuinely surprising. Here is an honest assessment of what is exciting, what is still missing, and where help is needed.

🔬
⚡ Exciting
Ketamine and Rapid Antidepressants
IV ketamine and intranasal esketamine (Spravato, FDA-approved 2019) produce antidepressant effects within hours, not weeks[9]. The NMDA glutamate mechanism is entirely distinct from SSRIs. For treatment-resistant depression, remission rates of 50-70% in acute phase. The question is duration and who maintains response. Research into optimal dosing schedules is active and promising.
🍄
⚡ Exciting
Psilocybin Phase 3 Trials
COMPASS Pathways, Usona Institute, and MAPS running large Phase 3 trials for treatment-resistant depression and MDD. Imperial College London found single-session psilocybin comparable to 6 weeks of SSRIs[4] for depression, with faster onset and longer duration. If Phase 3 results hold, we may see FDA approval in 2025-2027. The paradigm shift is real and evidence-based.
🧬
◎ Promising
Biomarker Discovery
Psychiatry has never had reliable biological markers for diagnosis. That is changing. Blood-based biomarkers for depression (IL-6, CRP inflammation markers, BDNF), EEG-based markers for treatment response prediction, and genomics for medication matching (pharmacogenomics) are showing clinical utility. Genesight and similar panels can predict which antidepressants will work for a given patient's genetics. Still imperfect; direction is right.
🧠
◎ Promising
Transcranial Magnetic Stimulation (TMS)
Non-invasive brain stimulation, FDA-cleared for depression and OCD. A new accelerated protocol (Stanford SAINT: 10 sessions in 5 days instead of 6 weeks) showed 90% remission in treatment-resistant depression in a small trial. Larger trials ongoing. If results replicate, this changes the calculus for severe cases dramatically.
🦠
◎ Promising
Gut Microbiome Interventions
The gut-brain axis is moving from hypothesis to mechanism. Specific bacterial strains (Lactobacillus rhamnosus, Bifidobacterium longum) show anxiolytic effects in animal and small human studies. Fecal microbiota transplant for severe depression is in Phase 2 trials. The vagus nerve as the communication channel between gut and brain is increasingly well-mapped. This is 5-10 years from clinical application but the direction is clear.
🤖
◎ Promising
Digital Therapeutics and AI
Prescription digital therapeutics (PDTs) are software programs FDA-cleared as medical treatments. Somryst (CBT-I for insomnia), Freespira (PTSD, panic disorder) have clinical trial evidence. AI-assisted therapy (Woebot, Wysa) shows modest but real effects for mild-moderate anxiety and depression. The scalability is the point: reaching populations who cannot access in-person care. Not a replacement for human therapy for severe conditions.
✗ What's Missing
Prevention and Early Intervention
Almost all mental health research focuses on treatment, not prevention. We know that 50% of lifetime mental health disorders begin by age 14, and 75% by age 24. We know that early intervention dramatically changes outcomes. We have almost no funded large-scale prevention programs. School-based mental health programs, community resilience building, and poverty reduction (the strongest predictor of mental health outcomes) are systematically underfunded relative to pharmaceutical research.
🌍
✗ What's Missing
Global Equity in Research
90% of mental health research comes from 10% of countries. Most clinical trials are conducted on Western, educated, industrialized, rich, democratic (WEIRD) populations. Treatments validated in the US or UK may not transfer culturally or biologically. Traditional healing practices in most of the world are almost entirely unresearched. This is a scientific failure with real human consequences: 75% of people in low-income countries receive no treatment, partly because we don't know what works for them.
How You Can Help · If You Want To

Clinical trial participation: clinicaltrials.gov lists every active trial by condition and location. Most need healthy controls, not just patients. Advocacy: NAMI, Mental Health America, and global equivalents run policy campaigns that have measurable legislative outcomes. Funding: the Brain and Behavior Research Foundation, One Mind, and Wellcome Trust fund high-risk high-reward mental health research that cannot get NIH grants. Locally: reducing stigma in your immediate environment has documented effects on treatment-seeking in people around you. The smallest radius of impact is not small.

· · · ·
The CPCS Framework · Philosophy · Mind and Matter

You Are an Electron

"An electron does not have a definite position. It exists in a probability cloud; a superposition of all the places it might be. It only 'decides' where it is when something interacts with it. Before that, it is everywhere and nowhere, simultaneously."

Here is the thing about electrons that does not get said enough in the context of mental health: the electron's uncertainty is not a failure of the electron. It is the fundamental nature of matter at the quantum scale. The electron is not broken because it cannot give you a fixed address. It is doing exactly what matter does.

Your mind works the same way. The experience of not knowing where you are, emotionally; of existing in a superposition of states; of feeling like you should be "somewhere definite" by now; is not a malfunction. It is the nature of consciousness interacting with an uncertain world.

The Pythagorean comma, the gap that prevents the musical spiral from closing, applies here too. There is a version of mental health that says: reach the resolved chord. Find stability. Close the loop. But the comma tells us something different. The spiral never closes. That is not a bug. It is the mechanism.

An electron jumps between energy levels. Not gradually; suddenly. This is a quantum leap: a discontinuous change in state. You cannot predict exactly when. You cannot watch it happen. You only know the before and the after.

Mental health crises feel like this. The descent is not always gradual. Recovery often isn't either. One day you are in one state. Then something interacts with you; a conversation, a medication, a morning with good light, a song; and you are in another state. The leap was real even if you cannot account for every step.

The electron has another property relevant here: it cannot be fully observed without changing. The act of measuring changes what is measured. This is also true of consciousness. The act of paying attention to your mental state changes it. Therapy works partly because articulating an experience changes the neural encoding of that experience. Journaling works for the same reason. Telling someone you are struggling changes the experience of struggling.

And finally: electrons are not solitary. They exist in fields, in atoms, in bonds. Their properties emerge from relationship, not isolation. The single most robust finding in mental health research over 80 years of data is this: social connection is protective. Isolation is pathogenic. Not because connection solves problems. But because consciousness, like the electron, is relational at its foundation.

You are made of particles that are in superposition, that make discontinuous leaps, that cannot be fully observed without changing, and that only make sense in relation to each other.

You were never supposed to be a fixed point. You were always supposed to be a wave.

References

APA 7th edition and ACS format.

[1]
APA  World Health Organization. (2022). World mental health report: Transforming mental health for all. WHO. https://www.who.int/publications/i/item/9789240049338
ACS  WHO. World Mental Health Report: Transforming Mental Health for All; WHO: Geneva, 2022.
[2]
APA  Pennebaker, J. W., & Seagal, J. D. (1999). Forming a story: The health benefits of narrative. Journal of Clinical Psychology, 55(10), 1243-1254. https://doi.org/10.1002/(SICI)1097-4679(199910)55:10<1243::AID-JCLP6>3.0.CO;2-N
ACS  Pennebaker, J. W.; Seagal, J. D. Forming a Story: The Health Benefits of Narrative. J. Clin. Psychol. 1999, 55 (10), 1243-1254.
[3]
APA  Singh, B., Olds, T., Curtis, R., Dumuid, D., Virgara, R., Watson, A., Szeto, K., O'Connor, E., Ferguson, T., Eglitis, E., Miatke, A., Simpson, C. E., & Maher, C. (2023). Effectiveness of physical activity interventions for improving depression, anxiety and distress: An overview of systematic reviews. British Journal of Sports Medicine, 57(18), 1203-1209. https://doi.org/10.1136/bjsports-2022-106195
ACS  Singh, B. et al. Effectiveness of Physical Activity Interventions for Improving Depression, Anxiety and Distress. Br. J. Sports Med. 2023, 57 (18), 1203-1209. DOI: 10.1136/bjsports-2022-106195
[4]
APA  Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder. JAMA Psychiatry, 78(5), 481-489. https://doi.org/10.1001/jamapsychiatry.2020.3285
ACS  Davis, A. K. et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder. JAMA Psychiatry 2021, 78 (5), 481-489. DOI: 10.1001/jamapsychiatry.2020.3285
[5]
APA  Walker, M. (2017). Why we sleep: Unlocking the power of sleep and dreams. Scribner.
ACS  Walker, M. Why We Sleep: Unlocking the Power of Sleep and Dreams; Scribner: New York, 2017.
[6]
APA  Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., Long-Smith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., … Dinan, T. G. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877-2013. https://doi.org/10.1152/physrev.00018.2018
ACS  Cryan, J. F. et al. The Microbiota-Gut-Brain Axis. Physiol. Rev. 2019, 99 (4), 1877-2013. DOI: 10.1152/physrev.00018.2018
[7]
APA  Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot'alora G., M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Mithoefer, A., Quevedo, S., Wells, G., Klaire, S. S., van der Kolk, B., … Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025-1033. https://doi.org/10.1038/s41591-021-01336-3
ACS  Mitchell, J. M. et al. MDMA-Assisted Therapy for Severe PTSD. Nat. Med. 2021, 27 (6), 1025-1033. DOI: 10.1038/s41591-021-01336-3
[8]
APA  National Alliance on Mental Illness. (2023). Mental health by the numbers. NAMI. https://www.nami.org/mhstats
ACS  NAMI. Mental Health by the Numbers; National Alliance on Mental Illness: Arlington, VA, 2023.
[9]
APA  Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., Charney, D. S., & Mathew, S. J. (2013). Antidepressant efficacy of ketamine in treatment-resistant major depression. Biological Psychiatry, 74(4), 250-256. https://doi.org/10.1016/j.biopsych.2012.12.014
ACS  Murrough, J. W. et al. Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression. Biol. Psychiatry 2013, 74 (4), 250-256. DOI: 10.1016/j.biopsych.2012.12.014

References

  1. World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates; WHO: Geneva, 2017.
  2. Chisholm, D.; Sweeny, K.; Sheehan, P.; et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry 2016, 3, 415-424.
  3. Golden, R. N.; Gaynes, B. N.; Ekstrom, R. D.; et al. The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence. Am. J. Psychiatry 2005, 162, 656-662.
  4. Shapiro, F. Eye Movement Desensitization and Reprocessing (EMDR) Therapy: Basic Principles, Protocols, and Procedures, 3rd ed.; Guilford Press: New York, 2018.
  5. Noetel, M.; Sanders, T.; Gallardo-Gómez, D.; et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ 2024, 384, e075847.
  6. Gershon, M. D.; Tack, J. The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology 2007, 132, 397-414.
  7. Lassale, C.; Batty, G. D.; Baghdadli, A.; et al. Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Mol. Psychiatry 2019, 24, 965-986.
  8. Davis, A. K.; Barrett, F. S.; May, D. G.; et al. Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry 2021, 78, 481-489.
  9. Mitchell, J. M.; Bogenschutz, M.; Lilienstein, A.; et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat. Med. 2021, 27, 1025-1033.
  10. Fedgchin, M.; Trivedi, M.; Daly, E. J.; et al. Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: Results of a randomized, double-blind, active-controlled study (TRANSFORM-1). Int. J. Neuropsychopharmacol. 2019, 22, 616-630.
  11. Bottomley, J. M.; LeReun, C.; Diamantopoulos, A.; et al. Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: A systematic review and meta-analysis. Compr. Psychiatry 2020, 98, 152156.
  12. Pennebaker, J. W.; Beall, S. K. Confronting a traumatic event: Toward an understanding of inhibition and disease. J. Abnorm. Psychol. 1986, 95, 274-281.
⚐ COMMA FRAMEWORK QUESTIONS
Open Questions

Speculative. Not claims. Invitations.

Every system manages a comma.What irresolvable gap is this subject managing?
Where is the Kairos event?N_res = 73.296. Is there a 73-unit threshold here?
The gap is not the failure.Where does the apparent error prove authenticity?
What does the 0.296 carry?What continues from a slightly different position?